Perspectives on COVID-19 control measures for ophthalmology clinics

March 31, 2020

What The Viewpoint Says: This article describes treatment initiatives being undertaken for novel coronavirus 2019 at an ophthalmology center in Singapore.

Authors: Ivan Seah Yu Jun, M.B.B.S., of  National University Hospital of Singapore, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaophthalmol.2020.1288)

Editor's Note: Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: The article is linked to this news release

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2020.1288?guestAccessKey=cfd3ac72-e954-47d8-b81b-c40f03672f57&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033120
-end-


JAMA Ophthalmology

Related Coronavirus Articles from Brightsurf:

Chemists discover the structure of a key coronavirus protein
MIT chemists have determined the molecular structure of a protein found in the SARS-CoV-2 virus.

Plasma treatments quickly kill coronavirus on surfaces
Researchers from UCLA believe using plasma could promise a significant breakthrough in the fight against the spread of COVID-19.

Cornea appears to resist infection from novel coronavirus
Some doctors have worried that the novel coronavirus may be able to infect people by getting into their eyes.

Study provides clues on curbing the aggressive nature of coronavirus
Recent study by Estonian researchers in University of Tartu explains how coronavirus is activated before attacking the cell and what could help to impede that.

Coronavirus mutation may have made it more contagious
A study involving more than 5,000 COVID-19 patients in Houston finds that the virus that causes the disease is accumulating genetic mutations, one of which may have made it more contagious.

Scientists map structure of potent antibody against coronavirus
Scientists at Fred Hutchinson Cancer Research Center in Seattle have shown that a potent antibody from a COVID-19 survivor interferes with a key feature on the surface of the coronavirus's distinctive spikes and induces critical pieces of those spikes to break off in the process.

Coronavirus volunteers: Greater satisfaction thanks to online platforms
Shortly after the lockdown began, a huge number of volunteers signed up to help people in coronavirus risk groups - primarily via online platforms.

Population currently sees coronavirus as the greatest health risk
The coronavirus is currently the population's main concern. More than a quarter of consumers perceive the virus as the greatest health risk.

Coronavirus: Study finds further door opener into the cell
The coronavirus SARS-CoV-2 is known to infect cells via the receptor ACE2.

Repurposing drugs for a pan-coronavirus treatment
The study identifies drug targets common to all three coronaviruses (SARS-CoV-2, SARS-CoV-1, and MERS-CoV) and potential drugs that could be repurposed as COVID-19 treatments.

Read More: Coronavirus News and Coronavirus Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.